OAM
CORV

Oxford Asset Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Oxford Asset Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-116,653
Closed -$48K – 1689
2019
Q4 		$48K Buy
+116,653
New +$194K ﹤0.01% 1670
2019
Q1 		– Sell
-36,260
Closed -$90K – 2158
2018
Q4 		$90K Buy
+36,260
New +$121K ﹤0.01% 1662

Other funds holding CORV

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Oxford Asset Management's CORV Position: Q1 2020 in Review

Oxford Asset Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2020, closing a stake of 116,653 shares — an estimated $48K sold.

Oxford Asset Management first reported a position in CORV in Q4 2018 and held it in 2 quarters. The position peaked at $90K in Q4 2018. 27 funds tracked by Wall St. Rank hold CORV as of Q1 2020.

  • Oxford Asset Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 116,653 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2020, an estimated $48K.
  • Oxford Asset Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2018 and held it in 2 quarters.
  • Oxford Asset Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $90K in Q4 2018.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.